An interview with Rachit Agarwal and Prabhash Choudhary, Team VIDA, who were runners up in Envision ’07 during Esummit. Envision is a product design and prototyping contest conducted by the Entrepreneurship Cell. TePP has approved an initial funding of Rs. 5 lacs for their product’s testing phase .
Excerpts from the interview:
TE: First of all, congratulations on the funding. What helped you ideate and come up with your novel bioreactor?
VIDA (their team) : Well, as such there were four people involved in this project – Prabash Choudhary, Sumit Jaiswal, Pawan Kumar and myself. Three of us were working in a biotech company for our summer internship, and as a side project were given the task of building a bioreactor. After coming back we realized that the bioreactor had great potential, and when ‘Envision’ came along, we decided to pursue it. After many modifications and with help from our mentor Prof. S. Dey [Dept. Of Biotechnology], we completed the project and submitted it, coming second in the competition.
TE: So, how was the feeling when you heard that your TePP proposal had been approved?
VIDA: It feels great. We really hadn’t thought about the proposal being approved, after such a long time since the competition. But yes, it does feel good. We along with Prof. Dey mentoring us, will get back to the project now.
TE: What are the advantages that your product has over other competitors?
VIDA: As such there are two widely used plant bioreactors, RITA and Growtek. Both these bioreactors have their own pros and cons, and are expensive. RITA, which is widely used in developed countries, costs around Rs. 3,500 for a single unit, while Growtek, developed by Prof. S Dey here at the Dept. of Biotechnology, costs about Rs. 280 per unit. Our bioreactor, on the other hand, will cost only about Rs. 35 per unit, making it much more affordable considering that research in this area is very expensive. What we did, was to make a product that was not only significantly cheaper but combined both of their functionalities.
TE: So filing and acquiring the patent must be your top priority now?
VIDA: It most definitely is, especially after the recent developments. I am already in touch with the lawyer.
TE: What are your future plans?
VIDA: We will first get a prototype ready and check out whether it satisfies the data we have collected. Development of plant bioreactors can be a little complicated, and we need to get test data first. It takes a significant amount of time, since we need to grow plants to test the reactors. We will think about recruiting some 2nd and 3rd years to help us out as well.
TE: So, was your ultimate aim while making the product, a profit making business model or a viable alternative for research which is inexpensive?
VIDA: The product is definitely aimed at research although it can generate profits as well. Yes, we will target developing countries with this product. This being a good alternative to the expensive
reactors used now.
TE: And how would you sum up the contribution of Envision and E-Cell?
VIDA: It is definitely different. A lot of people have ideas to improve products, which may not qualify as Bplans or technical plans, but are definitely marketable products. Even something like an improvement in mobile phone cover design could figure in that list. What Envision has successfully managed to do, is cater to this segment of people.
TE: Well, congratulations again and thanks for sharing your experience with us.